Ly F. Tu
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Sotatercept reduces bone morphogenetic protein signaling in patients with pulmonary arterial hypertension.
Journal: Science translational medicine
Published: May 20, 2026
BMP9 Modulates IL-33 Signaling to Mitigate EndMT in Pulmonary Arterial Hypertension.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: January 21, 2026
Novel role of von Willebrand factor-αvβ3 integrin in human pulmonary artery smooth muscle cell.
Journal: American journal of respiratory cell and molecular biology
Published: November 28, 2025
Impact of Pulmonary Arterial Hypertension Therapies on Gas Exchange in Portopulmonary Hypertension.
Journal: Chest
Published: October 27, 2025
Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.
Journal: Cardiovascular research
Published: October 13, 2025
Inactivation of the Phosphatase Activity of Soluble Epoxide Hydrolase Modulates SIRT3 and Attenuates Experimental Pulmonary Hypertension.
Journal: Comprehensive Physiology
Published: August 16, 2025
IDO-1 Promotes Pulmonary Vascular Remodeling Via Kynurenine Pathway in Pulmonary Arterial Hypertension.
Journal: Journal of the American Heart Association
Published: August 12, 2025
Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 23, 2025
Altered Ventilation in Rats With Established Severe Monocrotaline-Induced Pulmonary Hypertension: The Role of the Dorsal Hypothalamus.
Journal: Comprehensive Physiology
Published: June 20, 2025
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertension.
Journal: ERJ open research
Published: May 19, 2025
Soquelitinib inhibition of IL-2-inducible T cell kinase ameliorates lung damage in murine models of systemic sclerosis.
Journal: Arthritis research & therapy
Published: May 15, 2025
The activin pathway in chronic thromboembolic pulmonary hypertension: a potential biomarker for residual pulmonary hypertension after endarterectomy.
Journal: ERJ open research
Published: December 06, 2024
Last Updated: 09/26/2026